Omega Healthcare Investors, Inc. Forecast, price target & analysts
Omega Healthcare Investors, Inc. Target price 2025 - Analyst rating & recommendation
Omega Healthcare Investors, Inc. Classifications & Recommendation:
Omega Healthcare Investors, Inc. Price Target
| Target Price | $41.08 |
| Price | $36.84 |
| Potential |
11.50%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Omega Healthcare Investors, Inc. 2026 .
The average Omega Healthcare Investors, Inc. target price is $41.08.
This is
11.50%
register free of charge
$46.00
24.86%
register free of charge
$37.00
0.43%
register free of charge
|
|
| A rating was issued by 16 analysts: 7 Analysts recommend Omega Healthcare Investors, Inc. to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Omega Healthcare Investors, Inc. stock has an average upside potential 2026 of
11.50%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 1,062.39 | 935.31 |
| 10.14% | 11.96% | |
| EBITDA Margin | 91.67% | 115.61% |
| 8.44% | 26.11% | |
| Net Margin | 39.41% | 50.44% |
| 40.40% | 27.99% |
8 Analysts have issued a sales forecast Omega Healthcare Investors, Inc. 2025 . The average Omega Healthcare Investors, Inc. sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Omega Healthcare Investors, Inc. EBITDA forecast 2025. The average Omega Healthcare Investors, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Omega Healthcare Investors, Inc. 2025 . The average Omega Healthcare Investors, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.50 | 1.69 |
| 54.64% | 12.67% | |
| P/E | 21.80 | |
| EV/Sales | 15.94 |
1 Analysts have issued a Omega Healthcare Investors, Inc. forecast for earnings per share. The average Omega Healthcare Investors, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Omega Healthcare Investors, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Omega Healthcare Investors, Inc....
Current Omega Healthcare Investors, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JMP Securities | Locked ➜ Locked | Locked | Feb 07 2025 |
| BMO Capital | Locked ➜ Locked | Locked | Dec 09 2024 |
| Mizuho | Locked ➜ Locked | Locked | Dec 05 2024 |
| RBC Capital | Locked ➜ Locked | Locked | Nov 11 2024 |
| Berenberg | Locked ➜ Locked | Locked | Oct 18 2024 |
| BMO Capital | Locked ➜ Locked | Locked | Oct 07 2024 |
| Truist Securities | Locked ➜ Locked | Locked | Sep 04 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
JMP Securities: Locked ➜ Locked
|
Feb 07 2025 |
|
Locked
BMO Capital: Locked ➜ Locked
|
Dec 09 2024 |
|
Locked
Mizuho: Locked ➜ Locked
|
Dec 05 2024 |
|
Locked
RBC Capital: Locked ➜ Locked
|
Nov 11 2024 |
|
Locked
Berenberg: Locked ➜ Locked
|
Oct 18 2024 |
|
Locked
BMO Capital: Locked ➜ Locked
|
Oct 07 2024 |
|
Locked
Truist Securities: Locked ➜ Locked
|
Sep 04 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
